drugset / Trial / NCT00645216

Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety

NCT00645216

Phase 1 Completed 28 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

CP-945,598 is eliminated primarily by enzyme CYP3A. Grapefruit juice may affect the activity of CYP3A and alter the amount of CP-945,598 in the blood. This study will therefore compare the time course of drug concentrations in the body, safety and tolerability of CP-945,598 given with or without grapefruit juice in healthy obese/overweight subjects.

Timeline

Start
2007-06
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject OTENABANT Small molecule

Indications